AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL
· Real-Time Price · USD
4.62
0.12 (2.67%)
At close: Aug 15, 2025, 2:10 PM
AbCellera Biologics Revenue
AbCellera Biologics reported an annual revenue of $28.83M, reflecting a -24.17% growth. For the quarter ending March 31, 2025, AbCellera Biologics generated $4.24M in revenue.
Revenue (ttm)
28.83M
Revenue Growth
-24.17%
Price / Sales Ratio
29.91
Revenue / Employee
48.38K
Employees
596
Market Cap
1.38B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|